Genomic & Biopharma News

ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
ORB Company News, 2019-01-22 23:24:59

Amid push for J&J vaccine in Congo Ebola outbreak, health minister steps aside
As the WHO designated the Ebola outbreak in the Democratic Republic of Congo an international emergency, experts are pushing for the introduction of a second vaccine from J&J in the response.
Fierce Pharma, 2019-07-23 15:09:32

Acadia's Nuplazid flops schizophrenia trial on the heels of DOJ marketing probe
Acadia’s controversial antipsychosis med Nuplazid faced its share of scrutiny after a safety controversy drew federal eyeballs in March. Now, the drug has flopped a trial in schizophrenia, throwing a spanner into its pursuit of a first-ever adjunct approval.
Fierce Pharma, 2019-07-23 15:05:19

Teenagers who skip breakfast more likely to become obese
Researchers have found that young adults who skip breakfast are more likely to gain weight than those who eat breakfast.
News Medical Life Sciences, 2019-07-23 14:42:35

New color-changing tattoos can monitor glucose levels and other metabolites in real-time
Scientists in Germany have developed an intradermal tattoo that changes color in response to fluctuations in glucose, albumin, and pH levels.
News Medical Life Sciences, 2019-07-23 14:30:01

Key hires during Q2 2019 at ORB
Deerfield Beach, July 19, 2019 - Ocean Ridge Biosciences (ORB) announces two key hires in Q2 2019.
ORB Company News, 2019-07-20 00:49:36

Myovant's uterine fibroid med hits the mark in 2nd phase 3 trial
Myovant’s uterine fibroid drug relugolix reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies. The company plans to file for FDA approval in the fourth quarter.
Fierce Biotech, 2019-07-23 14:20:55

Chinese CDMO GenScript takes steps to be player in China's gene and cell therapy market
With western drugmakers taking new generation meds to China, GenScript Biotech is looking to be a key player in China’s CDMO market for biologics and cell and gene-based treatments. The Chinese company this week formally opened a new clinical supply manufacturing facility even as it is working on a commercial-scale facility nearby.
Fierce Pharma, 2019-07-23 14:10:05

Don't worry about Zolgensma, Biogen execs say. Spinraza has room to grow
Biogen executives were forced to explain why their SMA drug Spinraza stopped in its tracks last quarter. After all, the launch had been speeding along till now. One thing's for sure, management promised: It's not because of Novartis' new rival therapy Zolgensma.
Fierce Pharma, 2019-07-23 13:51:42

A $100B settlement? Or much less? Opioid payouts a mystery until J&J judge rules
After Johnson & Johnson's failed bid to toss out its Oklahoma marketing suit, analysts are wondering how high opioid settlements could go. Short answer: Who knows?
Fierce Pharma, 2019-07-23 13:46:11

Bayer recalls mislabeled vials of hemophilia A treatment
Bayer is scrambling to get its hands on nearly 1,000 vials of one of its top-selling drugs after a labeling mishap led to them being filled with the wrong hemophilia medicines. 
Fierce Pharma, 2019-07-23 13:28:44